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A national survey was conducted to determine the prevalence of Escherichia coli O26, O103, O111, and O145
in feces of Scottish cattle. In total, 6,086 fecal pats from 338 farms were tested. The weighted mean percentages
of farms on which shedding was detected were 23% for E. coli O26, 22% for E. coli O103, and 10% for E. coli
O145. The weighted mean prevalences in fecal pats were 4.6% for E. coli O26, 2.7% for E. coli O103, and 0.7%
for E. coliO145. No E. coliO111 was detected. Farms with cattle shedding E. coli serogroup O26, O103, or O145
were widely dispersed across Scotland and were identified most often in summer and autumn. However, on
individual farms, fecal shedding of E. coli O26, O103, or O145 was frequently undetectable or the numbers of
pats testing positive were small. For serogroup O26 or O103 there was clustering of positive pats within
management groups, and the presence of an animal shedding one of these serogroups was a positive predictor
for shedding by others, suggesting local transmission of infection. Carriage of vtx was rare in E. coli O103 and
O145 isolates, but 49.0% of E. coli O26 isolates possessed vtx, invariably vtx1 alone or vtx1 and vtx2 together. The
carriage of eae and ehxA genes was highly associated in all three serogroups. Among E. coli serogroup O26
isolates, 28.9% carried vtx, eae, and ehxA—a profile consistent with E. coli O26 strains known to cause human
disease.
Verocytotoxigenic Escherichia coli (VTEC) strains are im-
portant animal and human pathogens (18, 23, 24, 29, 31, 39,
50). In humans, VTEC strains are associated with illnesses
ranging from uncomplicated watery diarrhea to hemorrhagic
colitis and potentially fatal hemolytic uremic syndrome (50). In
North America, Japan, and much of Europe, the VTEC sero-
group usually associated with human disease is serogroup
O157 (3, 22). However, in parts of the southern hemisphere
and continental Europe, other VTEC serogroups are signifi-
cant causes of human disease (5, 10, 16, 28, 36, 46), especially
VTEC O26, O103, O111, and O145, which are highly associ-
ated with serious human infections (4, 8, 43, 49, 50). To date,
isolation of non-O157 VTEC strains from human infections
has been uncommon in Scotland (3) though VTEC serogroups
O26, O103, O111, and O145 are known to be carried by cattle
(47, 48, 50). This study was therefore undertaken to improve
our understanding of why non-O157 VTEC human infections
are uncommon in Scotland, and it had two major objectives.
The first was to conduct a national survey of the feces of
Scottish cattle to determine the prevalence of E. coli sero-
groups O26, O103, O111, and O145, which are potential
VTEC strains. The second objective was to screen bacterial
isolates for genes encoding enterohemolysin (ehxA) and the
virulence factors verocytotoxin 1 (vtx1), verocytotoxin 2 (vtx2),
and intimin (eae), which are associated with strains causing
human disease (7, 14, 23, 27, 38, 50, 51).
MATERIALS AND METHODS
The farms used as the sampling frame for the study were chosen from the 1997
Scottish Agricultural and Horticultural Census data and randomly selected
across all Scottish State Veterinary Service animal health divisions (AHDs). A
five-stage stratified sampling plan was used to select farms to ensure that similar
numbers were included from each stratum and that strata were sampled evenly
over time between March 2002 and February 2004. In each individual manage-
ment group, sufficient fecal pats from the sampled farms were tested to ensure an
80% chance of identifying at least one positive pat when there was at least one
shedding animal within the group, assuming a mean within-farm shedding prev-
alence of 7.8% on farms with positive-testing animals.
In total, tests were performed on 6,086 fecal pats collected from 338 farms,
representing 3.5% of Scottish farms with cattle of older than 1 year of age that
were store (i.e., young over-wintered animals) or were being finished for human
consumption (2003 Scottish Agricultural and Horticultural Census). In the indi-
vidual AHDs, from 51 to 59 farms and 912 to 1,142 fecal pats were sampled. In
each season, with winter defined as December, January, and February, spring as
March, April, and May, summer as June, July, and August, and autumn as
September, October, and November, from 79 to 90 farms and 1,291 to 1,748 fecal
pats were sampled. Fecal pat sampling was used because it was more practicable
and ensured higher farmer compliance than sampling individual animals, and the
results are thus representative of the Scottish cattle population and may be
regarded as a proxy for animal level prevalence.
Bacterial isolation was conducted within 48 h of sampling with 1 g of feces
from each sample preenriched in buffered peptone water and tested for the
presence of E. coli serogroup O26, O103, O111, or O145 by use of immunomag-
netic separation (IMS) and slide agglutination (35). All isolates provisionally
identified as belonging to serogroup O26, O103, O111, or O145 were further
tested by tube agglutination (32). All isolates with a positive tube agglutination
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result were submitted to The Laboratory of Enteric Pathogens, Health Protec-
tion Agency, Colindale, United Kingdom, and each isolate was biochemically
identified as E. coli and the somatic O antigens were confirmed (2, 25).
RESULTS AND DISCUSSION
Farm-level data. The mean percentages of farms with shed-
ding cattle were estimated using generalized linear mixed mod-
els (GLMMs) (9, 34), with binomial response terms and a logit
link function. Data were binary in form, so dispersion was set
equal to 1. Farm cluster and farm were fitted as random effects.
Including AHD and season as fixed effects, we used GLMMs
to determine the impact of AHD and season on the percentage
of farms with shedding cattle and to estimate the mean per-
centage of farms with shedding cattle in each AHD and season.
The GLMM parameter estimations were converted into mean
prevalences using both the transformed means and random
effects (12). National farm-level prevalence figures were de-
rived from these estimates using data defining the number of
cattle farms with cattle over 1 year of age in each AHD. A
confidence interval for the farm-level E. coli O111 mean prev-
alence estimate was derived numerically, assuming that the log
likelihood ratio associated with an absence of positive pats in
each AHD would be well approximated by a 2 distribution.
Confidence intervals for serogroup O26, O103, and O145
means were derived by reweighing output from the appropri-
ate GLMM. The effect of AHD on the mean prevalence of
farms with cattle shedding E. coli O145 was investigated fur-
ther using Fisher’s exact test, and log-linear generalized linear
models were used to examine associations between E. coli O26,
O103, and O145 shedding results on farms (44).
The observed number and percentage of farms positive for
each serogroup are given in Table 1. The slight bias in the raw
figure arises from the imbalance in the proportions of farms
sampled from different AHDs relative to their full populations.
The unbiased estimate of the mean percentage of farms in
Scotland with cattle shedding E. coli serogroup O26 was 23%
and was 22% for serogroup O103, which are results similar to
the mean percentage of farms with cattle shedding E. coli O157
(22.8%) (45). In contrast, the mean percentage of farms with
cattle shedding E. coli O145 (10%) was much lower.
Farms with cattle shedding E. coli serogroup O26, O103, or
O145 were widely dispersed across Scotland, with no statistical
evidence of regional differences in distribution, though shed-
ding of E. coli O145 was not detected on any farms in northeast
AHDs (Fig. 1). Season had a statistically significant effect (Fig. 2)
on the mean percentages of farms with cattle shedding E. coli
serogroups O26 (df3
2  13.04; P 0.005) and O103 (df3
2 
9.86; P  0.021), with positive results detected most frequently
in summer and autumn. A similar trend, but with no detectable
significant seasonal effect (P  0.44), was seen for the percent-
age of farms with cattle shedding E. coli O145.
Pat-level data, all farms. For the whole of Scotland and
within each AHD and season, the distribution of the mean
percentages of positive pats was approximated using bootstrap-
ping procedures (13), as the skewed and potentially bimodal
distribution of the data resulted in poorly fitted GLMMs. Each
bootstrap exercise comprised 10,000 iterations of a two-stage
bootstrapping procedure. Within each iteration, farm clusters
were sampled with replacement, all farms were sampled within
each cluster, all management groups were sampled within each
farm, and pats were sampled with replacement in each man-
agement group. The contribution of each sampled pat was
weighted by the inverse of the probability of selection from its
management group. Differences in the observed prevalences
between AHDs and seasons were each assessed by generating
bootstrap samples under the null hypothesis that the distribu-
tional properties were the same over the entire data set (13).
The coexistence of E. coli O26, O103, or O145 strains in pats
was analyzed using log-linear models (44).
The observed numbers and percentages of positive pats for
each serogroup are given in Table 2 with a weighted, unbiased
prevalence estimate and confidence interval. The bias in the
raw figure arises because a larger percentage of pats were
sampled from small management groups. The unbiased esti-
mates of the pat-level prevalences of E. coli O26, O103, and
O145 shedding by cattle over 1 year old across Scotland are
4.6%, 2.7%, and 0.7%, respectively. The mean pat-level prev-
alence of E. coli O26 detected by IMS is slightly more than
one-half the prevalence of E. coli O157 (7.9%) previously
described using similar methods (45). For all three serogroups
the observed pat-level shedding was highest in summer and
autumn, but across all farms, there was a statistically significant
effect of season on only the mean percentage of pats positive
for E. coli serogroup O103 (P  0.04).
E. coli of serogroup O111 was not found in any samples, and no
upper confidence boundary is calculated for its prevalence be-
cause any meaningful estimate would require information about
the clustering of positive samples. The absence of E. coli O111 is
consistent with the results of Scottish studies that used IMS and
also PCR with DNA hybridization techniques (19, 20, 35), though
E. coli O111 has been previously isolated from cattle (26, 39, 47,
48) and there is a report of the isolation of this serogroup from
United Kingdom cattle in the early 1980s (41).
On individual farms, fecal shedding of E. coli O26, O103, or
O145 was usually undetectable or the number of positive pats
was small (Fig. 3). However, the observed pat-level preva-
lences of shedding ranged widely between management groups
on different farms. Within sampled groups, 0% to 83% of
samples were positive for E. coli serogroup O26, 0% to 55%
for serogroup O103, and 0% to 25% for serogroup O145.
Clustering of shedding is thus evident within management
groups, and the presence of an animal shedding serogroup O26
or O103 is a positive predictor for shedding by other cattle in
the group. There is no statistical evidence that within a group
the mean percentage of pats positive for serogroups O26,
TABLE 1. Numbers, observed percentages, and weighted mean
percentages of farms with one or more store or finishing
cattle shedding E. coli O26, O103, O111, or O145
Serogroup
No. of farms
with positive
results
Observed
%
Weighted mean
%
95% Confidence
limits
Lower Upper
O26 68 20 23 18 29
O103 75 22 22 17 27
O111 0 0 0 0 2
O145 26 8 10 4 21
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O103, or O145 is correlated with group size, and there is no
strong evidence for a correlation between results showing
the presence of the different E. coli serogroups O26, O103,
and O145. These findings most likely suggest local transmis-
sion of infection, though an unknown highly localized risk
factor cannot be excluded.
Pat-level data, farms with shedding cattle. GLMMs with a
binomial response distribution and a logit link function were
used to estimate the mean percentage of pats positive for
the subsets of positive farms, fitting farm cluster, farm, and
sample group as random effects. Incorporating AHD and
season as fixed effects, the models were used to determine
FIG. 1. Location of Scottish State Veterinary Service animal health divisions and sampled farms with store and finishing cattle shedding E. coli
serogroups O26 and O103 or O145. Animal health divisions: 1, Highlands; 2, North East; 3, Central; 4, South West; 5, South East; 6, Islands. E,
no shedding detected; F, shedding detected. (Map reprinted with the permission of the ESRC.)
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the impact of these factors on the mean percentage of pos-
itive pats.
In the farms with positive-testing animals, for each of sero-
groups O26, O103, and O145, there was no statistical evidence
of any association between season or AHD and the mean
percentage of positive pats. Intriguingly, our results thus indi-
cated an increase in the number of farms with shedding cattle
rather than a rise in the number of cattle shedding on farms
where shedding is occurring. Other studies have reported that
the percentage of farms with cattle shedding E. coli O157 is
highest in summer and autumn (15, 40) or that the mean level
of E. coli O157 shedding among cattle is highest in summer and
autumn (17). The reasons for the apparent seasonality in shed-
ding are not known. However, the pattern is reflected in the
reported number of human cases of E. coli O157 infection,
which also rise in summer (3, 42), though, so far as we are
aware, no seasonal pattern of human infection with serogroup
O26, O103, or O145 has been reported.
Molecular characterization of bacterial isolates. The second
study objective was to screen by multiplex PCR (33) all bacte-
rial isolates for genes encoding enterohemolysin (ehxA) and
the virulence factors verocytotoxin 1 (vtx1), verocytotoxin 2
(vtx2), and intimin (eae) that are associated with strains causing
human disease (7, 14, 23, 27, 38, 50, 51). Carriage of the genes
vtx1, vtx2, eae, and ehxA by E. coli serogroup O26, O103, and
O145 isolates is shown in Table 3. A total of 122 (49.0%) E.
coli O26 isolates carried vtx1, and 31 (12.5% of the total) of
these also had vtx2. No E. coli O26 isolates carried vtx2 alone.
A high percentage (83.9%) of serogroup O26 isolates pos-
sessed the eae gene, while approximately half (51.8%) carried
ehxA. For E. coli serogroup O26 isolates there were 72 (28.9%)
that carried vtx1, eae, and ehxA genes; these results are consis-
tent with strains pathogenic to humans (7, 38, 51). Carriage of
vtx genes was rare in serogroup O103 and O145 isolates. Only
2 of 168 (1.2%) serogroup O103 isolates were vtx positive: one
carried vtx1, while the other possessed both vtx1 and vtx2. Among
serogroup O145 isolates, 2 of 43 (4.7%) carried vtx genes: one
carried vtx1 and the other vtx2.
Associations between isolate virulence factors were assessed
using contingency tables and Fisher’s exact test (44). For se-
rogroup O26 the percentage of vtx-negative isolates with eae
(88.2%) was not significantly different from the percentage of
vtx-positive isolates with eae (79.5%), but isolates with eae were
12 times more likely to carry ehxA than isolates without eae
(P  0.001; relative risk, 12.2; 95% confidence interval, 3.1 to
47.1). In serogroups O103 and O145, carriage of eae and ehxA
was also common, and as has been previously noted (6, 7),
these genes were highly associated (P  0.001 and P  0.001,
respectively). While both eae and ehxA encode putative viru-
lence determinants, the isolates from cattle that are eae posi-
tive but vtx negative are generally regarded as atypical enter-
opathogenic E. coli and may be less likely than VTEC to cause
human disease (37).
Most studies of non-O157 E. coli shedding by cattle detected
strains by screening for verocytotoxin production or the pres-
ence of vtx genes and therefore present results biased to VTEC
alone. The IMS technique is advantageous in being directed
toward isolation of target serogroup strains irrespective of vtx
gene carriage. Previous work has shown that, for the detection
of VTEC O26, the IMS technique used is 2.5 times more
sensitive than replica colony plating and DNA hybridization
with vtx probes (21). IMS is also more sensitive for detection of
FIG. 2. Mean percentage of farms with fecal pats from store and finishing cattle positive for E. coli O26, O103, or O145 by season. Error bars
define 95% confidence limits.
TABLE 2. Numbers, observed percentages, and weighted mean
percentages of fecal pats shed by store or finishing cattle
positive for E. coli O26, O103, O111, or O145
Serogroup No. ofpositive pats
Observed
%
Weighted mean
%
95% Confidence
limits
Lower Upper
O26 249 4.1 4.6 3.0 6.6
O103 168 2.8 2.7 1.7 3.8
O111 0 0.0 0.0 0.0 NCa
O145 43 0.7 0.7 0.3 1.2
a NC, not calculated.
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E. coli O157 (11). We thus believe that the IMS technique is a
valuable tool in the epidemiological study of VTEC and that
our prevalence data with identification of low prevalences of
VTEC O103, O111, and O145 in Scottish cattle more than 1
year old are more accurate than data from other estimates (1,
26, 35).
The scale of this study is larger than any described in the
literature and establishes a benchmark for the prevalence of
VTEC O26, O103, O111, and O145 carriage by cattle in Scot-
land and establishes that VTEC O26 strains are common and
widely dispersed. However, the prevalence figures for each E.
coli serogroup in this study should be regarded as minimum
prevalence estimates as our sampling procedure is designed to
give an 80% chance of detecting at least one positive pat from
a group if one or more animals were shedding in that group.
Additionally, the development and validation of indicator me-
dia could increase the sensitivity of detection and, therefore,
the accuracy of prevalence estimates, as has happened with E.
coli O157 studies.
VTEC serogroup O26 is important as a cause of human
infection in central and southern Europe (46, 51), and in Italy
this serogroup has surpassed E. coli O157 as the major cause of
hemorrhagic colitis and hemolytic uremic syndrome (46).
Though human disease associated with E. coli O26 has oc-
curred in England (42), Scotland (3), and the Republic of
Ireland (30), the number of serogroup O26 infections reported
is very much smaller than for E. coli O157. There could be
many reasons for the marked differences in the occurrence in
United Kingdom of human infections caused by VTEC of E.
coli O157 and O26 serogroups. However, the common finding
in Scottish cattle of E. coli serogroup O26 isolates that are
consistent with strains pathogenic to humans (7, 38, 51) is of
significance. The results raise the issue of whether VTEC O26
strains from cattle pose a human health hazard and whether
this serogroup may emerge to become a cause of human in-
fections in Scotland. To investigate this further, our prelimi-
nary studies are focusing on a comparison of E. coli O26
FIG. 3. Number of pats positive for E. coli O26, O103, or O145 on
sampled farms.
TABLE 3. E. coli serogroup O26, O103, and O145 isolates and
carriage of genes encoding verocytotoxin 1 (vtx1), verocytotoxin
2 (vtx2), intimin (eae), and enterohemolysin (ehxA)
Serogroup
Virulence factor gene result a Total no.
of isolatesvtx1 vtx2 eae ehxA
O26     15
    57
    55
    16
    2
    20
    53
    7
    5
    19
Total 122 31 209 129 249
O103     103
    2
    61
    1
    1
Total 2 1 64 62 168
O145     7
    8
    26
    1
    1
Total 1 1 36 28 43
a Totals in columns represent numbers of isolates tested.
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isolates from humans and animals that have been collected
from across Europe.
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